Company Profile
Hangzhou Yueding Technology Co.,Ltd (named as Xinchang Yueding Chemical Co.Ltd before), established on 2006. We are specializing in the food additives, feed additives. Besides, we establish a high-technology enterprise specialises in the research and development of peptide drugs. We devote ourselves to the reaearch and development of new gene protein drugs and unnatural amino acid as well as supplying of customermized peptide.
VIEW MORE VIEW LESSProduct List
| Product Name | Synonyms | CAS No. | Grate/Content | Operate |
|---|---|---|---|---|
Bivalirudin |
128270-60-0 | Inquiry | ||
CARBETOCIN |
37025-55-1 | Inquiry | ||
Glatiramer Acetate |
L-Glutamic acid,polymer with L-alanine,L-lysine and L-tyrosine,acetate (salt);L-Alanine,polymer with L-glutamic acid,L-lysine and L-tyrosine,acetate (salt);L-Lysine,polymer with L-alanine,L-glutamic acid and L-tyrosine,acetate (salt);L-Tyrosine,polymer with L-alanine,L-glutamic acid and L-lysine,acetate (salt);L-Glutamic acid peptide with L-alanine,L-lysine and L-tyrosine,acetate (salt);Cop 1;Cop 1 (polyamide);Glatiramer acetate;Copaxone;Copolymer 1;Protiramer;TV 5010;511: PN: WO2010103292 PAGE: 64 claimed sequence;Probioglat;Polimunol;Escadra;Natco;Hangzhou;Axoglatiran FS;Glatopa;M 356;943513-95-9 |
147245-92-9 | Inquiry | |
Octreotide Acetate |
ctreotide;DARAMONOL;OXTREOTIDE;Longastatin;Octreotide acetate;Octreotode Acetate;Ocetreotide, Acetate;APIOC OCTREOTIDE ACETATE;OCTREOTIDE ACETATE (GMP);H-D-Phe-Cys-Phe-D-Trp-Lys-Thr-Cys-L-threoninol acetate salt (Disulfide bond) |
83150-76-9 | Inquiry | |
Oxytocin Acetate |
OT;OXT;pitons;OT-NPI;atonino;oxystin;pitocin;piton-s;utedrin;OXTOCIN |
50-56-6 | Inquiry | |
Terlipressin Acetate |
[N-α-Triglycyl-8-lysine]-vasopressin;130: PN: WO2010033207 SEQID: 171 claiMed protein;1-Triglycyl-8-lysine Vasopressin;Nα-Glycyl-glycyl-glycyl-[8-lysine]-vasopressin;Nα-Glycyl-glycyl-glycyl-lysine-vasopressin;Nα-Glycylglycylglycyl-vasopressin;Nα-Gly-Gly-Gly-8-Lys-vasopressin;Triglycyl-8-lysine-vasopressin |
14636-12-5 | Inquiry |
CONTACT INFORMATION
Sign In for Details